Author: Neumann-Podczaska, Agnieszka; Chojnicki, Michal; Karbowski, Lukasz M.; Al-Saad, Salwan R.; Hashmi, Abbas A.; Chudek, Jerzy; Tobis, Slawomir; Kropinska, Sylwia; Mozer-Lisewska, Iwona; Suwalska, Aleksandra; Tykarski, Andrzej; Wieczorowska-Tobis, Katarzyna
Title: Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome Cord-id: ugskomrx Document date: 2020_11_12
ID: ugskomrx
Snippet: The older population is one of the most vulnerable to experience adverse outcomes of COVID-19. Exploring different clinical features that may act as detrimental to this population’s survival is pivotal for recognizing the highest risk individuals for poor outcome. We thus aimed to characterize the clinical differences between 60-day survivors and non-survivors, as well as analyze variables influencing survival in the first older adults hospitalized in Poznan, Poland, with COVID-19. Symptoms, c
Document: The older population is one of the most vulnerable to experience adverse outcomes of COVID-19. Exploring different clinical features that may act as detrimental to this population’s survival is pivotal for recognizing the highest risk individuals for poor outcome. We thus aimed to characterize the clinical differences between 60-day survivors and non-survivors, as well as analyze variables influencing survival in the first older adults hospitalized in Poznan, Poland, with COVID-19. Symptoms, comorbidities, complications, laboratory results, and functional capacity regarding the first 50 older patients (≥60 years) hospitalized due to COVID-19 were retrospectively studied. Functional status before admission (dependent/independent) was determined based on medical history. The 60-day survivors (n = 30/50) and non-survivors (n = 20/50) were compared across clinical parameters. The patients had a mean age of 74.8 ± 9.4 years. Overall, 20/50 patients died during hospitalization, with no further fatal outcomes reported during the 60-day period. The non-survivors were on average older (78.3 ± 9.7 years), more commonly experienced concurrent heart disease (75%), and displayed functional dependence (65%) (p < 0.05). When assessing the variables influencing survival (age, heart disease, and functional dependence), using a multivariate proportional hazards regression, functional dependence (requiring assistance in core activities of daily living) was the main factor affecting 60-day survival (HR, 3.34; 95% CI: 1.29–8.63; p = 0.01). In our study, functional dependence was the most important prognostic factor associated with mortality. Elderly with COVID-19 who required assistance in core activities of daily living prior to hospitalization had a three times increased risk to experience mortality, as compared to those with complete independence. Exploring geriatric approaches, such as assessment of functional capacity, may assist in constructing comprehensive survival prognosis in the elderly COVID-19 population.
Search related documents:
Co phrase search for related documents- admission date and lopinavir ritonavir: 1, 2, 3
- admission date and lung involvement: 1, 2
- admission ldh and liver function: 1
- admission ldh and liver kidney: 1
- admission ldh and lopinavir ritonavir: 1
- admission ldh and lung involvement: 1, 2
- admission symptom and liver function: 1
- admission symptom and liver kidney: 1, 2
- admission symptom and low molecular: 1
- admission symptom and lung involvement: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date